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Transcriptional activation of transforming growth factor-b1 in
mesangial cell culture by high glucose concentration.
Background. Transforming growth factor-b (TGF-b) is an im-
portant hypertrophic and prosclerotic cytokine in the pathogene-
sis of diabetic nephropathy. The mechanisms of regulation of the
TGF-b system by high ambient glucose in kidney cells are
incompletely defined. This study examined the mechanisms of
regulation of TGF-b1 expression by high glucose in murine
mesangial cells (MMCs) in culture.
Methods. MMCs were cultured in either normal (100 mg/dl) or
high (450 mg/dl) D-glucose concentration. Total TGF-b1 protein
secretion and bioactivity, mRNA expression and stability, and
gene transcription rate were measured; promoter-reporter chlor-
amphenicol acetyltransferase (CAT) assays and electrophoretic
mobility shift assay (EMSA) were performed to investigate the
presence of putative glucose-response elements.
Results. Raising the ambient D-glucose concentration for 72
hours increased TGF-b1 bioactivity in cell culture medium by
47% and total TGF-b1 secretion by approximately 90%. Northern
analysis demonstrated that the steady-state TGF-b1 mRNA level
was increased nearly twofold after 48 hours of growth in high
glucose. This increase was not due to increased stability, as the
half-life of the message was approximately five hours in both
normal and high glucose conditions. Transcriptional activity of the
TGF-b1 gene (nuclear run-on assay) was increased by 73% in cells
grown in high glucose for 24 hours. Transiently transfected MMCs
with CAT constructs containing varying lengths of the murine
TGF-b1 promoter demonstrated that high glucose selectively
increased the expression of only one of the constructs, pA835.
Sequence inspection revealed the presence of a putative glucose
responsive element, CACGTG, within this construct. High glu-
cose in MMC culture for 24 hours increased nuclear protein
binding to a probe containing this element when analyzed using
EMSA.
Conclusions. High glucose stimulates total TGF-b1 protein
production and bioactivity as well as the steady-state level of
TGF-b1 mRNA. The latter effect is due primarily to stimulation
of gene transcription rate rather than message stability. Transcrip-
tional activation by high glucose may involve a region in the
TGF-b1 promoter containing a putative glucose-response ele-
ment.
Diabetic nephropathy is the major cause of kidney failure
in the industrialized world. Although genetic [1] and he-
modynamic factors [2] play important roles, the mecha-
nisms initiating kidney damage undoubtedly stem from
chronic hyperglycemia and its metabolic consequences.
Clinical trials have revealed that poor glycemic control
predicts the incidence and progression of diabetic retinop-
athy, neuropathy, and renal disease [3]. Previous studies of
the effects of high glucose concentration on renal cells in
tissue culture have demonstrated ’direct’ alterations in
cellular parameters which are highly relevant to diabetic
renal disease, such as cellular hypertrophy, enhanced ex-
tracellular matrix production, and altered production or
action of growth factors [reviewed in 4]. In particular, the
multifunctional cytokine TGF-b has received paramount
attention as a likely etiologic agent in the pathogenesis of
diabetic nephropathy [5]. TGF-b plays a pivotal role in
cellular growth and extracellular matrix production [6–8].
Many of the actions of TGF-b on renal cells resemble those
of high ambient glucose and are reminiscent of the diabetic
changes that are seen in the kidney [9, 10].
It now appears likely that the hypertrophic and proscle-
rotic effects of high glucose concentration on cultured
glomerular mesangial cells [11, 12], glomerular epithelial
cells [13], and renal proximal tubular cells [14, 15] are
mediated by autocrine production and activation of TGF-b.
For instance, we have shown that expression of TGF-b1
mRNA and bioactivity are significantly increased within 48
hours of exposure to high ambient glucose in murine
proximal tubular cells and glomerular mesangial cells [11,
12, 16]. Inhibiting TGF-b activity with specific neutralizing
antibodies [11–13, 16, 17] or by application of TGF-b1
antisense oligonucleotides [18] attenuates the glucose-in-
duced inhibition of cell proliferation and the stimulated
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synthesis of matrix molecules such as types I and IV
collagen, fibronectin, and mesangial proteoglycans.
The mechanisms of regulation of the TGF-b system by
high glucose in kidney cells are incompletely defined.
Modulation of bioactivity may occur through pre-transla-
tional or post-translational mechanisms. The latter may
involve changes in ligand processing and activation or
alterations in receptor number and dimerization. Regions
within the untranslated portions of the TGF-b1 gene are
involved in post-transcriptional processing of the message
in some cell types [19]. Previous studies have also shown
that one likely point of regulation of TGF-b1 expression by
high glucose media in mesangial cells is at the mRNA level
[11, 18], but it remains unclear whether increased steady-
state levels of TGF-b1 mRNA by high glucose are due to
increased rate of gene transcription or a result of transcript
stability. The promoter regions of the TGF-b1 gene in
mouse and humans contain several consensus binding sites
for known transcription factors including SP1, AP1 and
AP2 [20–22]. High ambient glucose in mesangial cell
culture has been shown to increase the expression of c-jun
and c-fos, proteins that dimerize to form the AP1 transcrip-
tion factor [23]. SP1 may function as a glucose-responsive
element in the promoter region of a gene involved in
glucose metabolism [24]. In addition, inspection of the
murine promoter region of TGF-b1 between 2641 and
2636 59 to the A transcription start-site [21] reveals a
sequence that has previously been described in the S14 and
pyruvate kinase genes to be glucose-responsive [25, 26].
This 59-CACGTG-39 element is a consensus sequence
recognized by a family of transcription factors containing a
conserved basic region, helix loop-helix, leucine zipper
domain, which includes the c-myc family. It is currently not
known if any of the elements mentioned above functions as
a glucose-response element that can mediate TGF-b1
transcriptional activation by high ambient glucose in mes-
angial cells.
In the present study we set out to better understand the
mechanisms of regulation of TGF-b1 expression by high
ambient glucose in murine mesangial cells in culture. We
demonstrate that high glucose stimulates total TGF-b1
protein production and bioactivity as well as the steady-
state level of TGF-b1 mRNA. The latter effect is due
primarily to stimulation of gene transcription rate rather
than to message stability. Promoter-reporter assays and
DNA-nuclear protein analysis suggest that transcriptional
activation by high glucose involves a region in the TGF-b1




A murine mesangial cell line (MMC) was used. Cells
were originally isolated from kidneys of SJL/J(H-2) normal
mice and transformed with noncapsid forming SV-40 virus
to establish a permanent cell line [27]. The cells exhibit
many phenotypic features of differentiated mesangial cells
including positive staining for desmin, vimentin, and colla-
gen types I and IV. Cells were maintained at 37°C in a
humidified incubator with 5% CO2/95% air and propa-
gated in Dulbecco’s modified essential medium (DMEM;
GIBCO BRL, Gaithersburg, MD, USA) containing 100
mg/dl D-glucose, 10% fetal calf serum (FCS), 100 U/ml
penicillin, 100 mg/ml streptomycin, and 2 mM supplemental
glutamine. Cells were passaged every 72 hours by light
trypsinization. Experiments were initiated by resting cells
for 24 hours in 0.5% FCS. Fresh DMEM was then added
containing 0.5% FCS and 100 mg/dl D-glucose (unless
specified otherwise) and the D-glucose concentration was
increased in some plates to specified concentrations (up to
600 mg/dl) by the addition of a small volume of 1.0 M
D-glucose in sterile water. D-mannitol was used as an
osmotic control. In some experiments cells were treated
with recombinant human TGF-b1 (R & D Systems, Min-
neapolis, MN, USA) at 1 ng/ml for 24 hours or with
phorbol 12-myristate 13-acetate (PMA; Sigma, St. Louis,
MO, USA) at 100 nM for six hours. Media and cells were
harvested after a period of 24, 48, 72, or 96 hours as
specifically indicated.
TGF-b1 ELISA
Conditioned media were frozen at 220°C until assayed
by a sandwich ELISA kit according to the manufacturer’s
specifications (Genzyme, Boston, MA, USA). Acid activa-
tion of the samples was required in order to convert latent
into active TGF-b1 and to record detectable levels of total
(latent 1 active) TGF-b1. Samples were thawed and
activated with 1 N HCl for 60 minutes at 4°C followed by
neutralization with 1 N NaOH. Samples were plated on
anti-TGF-b1-coated microtiter plates and incubated at
37°C for 60 minutes. After vigorous washing, wells were
incubated with a second biotin-conjugated anti-TGF-b1
antibody and the peroxidase reaction was initiated. A
standard curve was constructed using serial dilutions of
ultrapure human TGF-b1 (Genzyme). TGF-b1 levels in
samples were compared to known standards and read as
ng/ml, and final concentrations were reported per cell
number or total cell protein content (Bio-Rad, Richmond,
CA, USA).
TGF-b1 bioassay
A highly sensitive bioassay for TGF-b1 was conducted
using a reporter mink-lung epithelial cell line that had been
stably transfected with a plasminogen activator-inhibitor-1
(PAI-1) promoter linked to luciferase reporter gene [28].
The PAI-1 promoter is very sensitive to stimulation by
TGF-b1 and can measure levels as low as 2 pg/ml. The
mink cells were plated onto 96-well microtiter plates in
DMEM containing 1% FCS. After allowing cells to adhere
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to the wells for three hours, serial dilutions of TGF-b1
standard or conditioned media from mesangial cells (1:1
dilution) were added to the medium of the reporter cells
and incubated for 24 hours, at which time cells were
harvested and the cell lysate was assayed for luciferase
activity in a luminometer [29]. Protein in the cell lysates was
measured (Bio-Rad), and bioactivity was reported per cell
protein content. To assure specificity, samples were pre-
treated with neutralizing anti-TGF-b antibodies (pan-spe-
cific against TGF-b1, b2, and b3; Genzyme) at a concen-
tration of 10 mg/ml prior to addition to wells. We found that
more than 90% of bioactivity was neutralized with this
concentration of antibody.
Northern analysis
At the end of the incubation period (24, 48, and 72 hr),
cells were washed in RNAse-free PBS (pH 7.2), and
directly lysed and denatured in 4 M guanidinium thiocya-
nate, 25 mM sodium citrate, pH 7.0, 0.5% sarcosyl, and 0.1
M 2-mercaptoethanol. Total RNA was isolated by repeated
phenol-chloroform extractions as previously described [12].
RNA was separated (20 mg) on a 1.2% agarose gel con-
taining 0.67 M formaldehyde, transferred to Gene-Screen
nylon membrane (NEN Research Products, Boston, MA,
USA) by capillary blotting and UV-crosslinked. Integrity
and equal loading of RNA samples were assessed by
methylene blue staining of the transferred RNA [30]. All
cDNA inserts were separated from their plasmids in low-
melt agarose and labeled with 32P-dCTP (Amersham,
Arlington Heights, IL, USA) using a random-priming kit
(Boehringer Mannheim, Indianapolis, IN, USA). The
cDNA probes encoding murine TGF-b1 and 18S were as
previously described [30]. The labeled cDNAs were sepa-
rated from unincorporated nucleotides by passage over a
NENSORB purification cartridge (NEN Research Prod-
ucts) and membranes were hybridized with 106 cpm/ml
probe. Details of the hybridization, washing, and autora-
diography were performed as previously reported [12].
Exposed X-ray films (18 hr to 4 days) were scanned with a
laser-densitometer, and TGF-b1 mRNA level was calcu-
lated relative to that of 18S. Measurements of this ratio in
MMCs cultured in 100 mg/dl glucose were assigned a
relative value of one.
Message stability assay
Rested MMCs (107 cells) were cultured for 48 hours in
DMEM 1 0.5% FCS containing either 100 mg/dl or 450
mg/dl glucose concentration. Cells were then treated with 5
mg/ml Actinomycin D (Boehringer Mannheim) to inhibit
RNA synthesis and total RNA was extracted after specified
time periods (between 0 and 16 hr). Northern analysis and
hybridization for TGF-b1 and 18S were performed as
outlined above to measure the rate of decay of TGF-b1
mRNA and the half-life. Measurement of the ratio of
TGF-b1/18S at time 5 0 (from Actinomycin D treatment)
in cells cultured in 100 mg/dl glucose was assigned a relative
value of one, or 100%.
Nuclear run-on assay
Isolation of nuclei and in vitro transcription were per-
formed according to established methods [31] with some
modification. Briefly, rested MMCs were grown in 100 mm
plates in DMEM 1 0.5% FCS in the presence of either 100
mg/dl or 450 mg/dl glucose for 24 hours. Cells were rinsed
in ice cold PBS and nuclei were isolated [31] and stored at
270°C for future use. For in vitro transcription, the nuclei
were thawed in an equal volume of reaction buffer (10 mM
Tris-Cl, pH 8.0, 5 mM MgCl2, 0.3 M KCl) containing 1 mM
each of adenosine 59-triphosphate (ATP), guanosine 59-
triphosphate (GTP), cytidine 59-triphosphate (CTP), and 5
mM dithiothreitol (DTT). One hundred mCi of a-32P-
uridine triphosphate (UTP; Amersham) and 2 ml RNAsin
(Promega, Madison, WI, USA) were added to each reac-
tion and then incubated at 30°C for 30 minutes. 32P-labeled
RNA was then isolated using Trisolv reagent (Biotecx Lab.,
Inc., Houston, TX), ethanol-precipitated and dissolved in
500 ml TES buffer (10 mM Tris-Cl pH 7.4; 10 mM EDTA;
0.2% SDS, 0.6 M NaCl; 63 Denhardt’s). Equal counts were
then hybridized to linearized DNA (18S, TGF-b1) between
1 to 2 mg, that had been cut from plasmid and immobilized
on nylon membranes using a slot-blot apparatus. The
nonspecific vector plasmid pBsks was used as a negative
control. Hybridization was carried out for 30 hours at 60°C
in a solution containing 1 3 Northern prehybridization
buffer (5 Prime-3 Prime, Inc., Boulder, CO, USA), 5%
SDS, 5% dextran sulfate, 10% Blocking Reagent (Biotecx
Lab), yeast tRNA and sheared salmon sperm DNA. Mem-
branes were then washed in 2 3 SSC for one hour at 60°C,
incubated at 37°C for 30 minutes in 10 mg/ml ribonuclease
A (Sigma) washed again for one hour in 2 3 SSC at 37°C,
air-dried, and exposed to film (XAR-5; Eastman Kodak Co,
Rochester NY, USA) with intensifying screens at 270°C.
Exposed films were scanned with a laser-densitometer
(Hoefer Scientific Instruments, San Francisco, CA, USA),
and TGF-b1 levels were calculated relative to those of 18S.
Measurements of this ratio in cells cultured in 100 mg/dl
glucose were assigned a relative value of one, or 100%.
Transfections, CAT constructs and CAT assay
Murine TGF-b1 promoter-reporter chimeric constructs
were kindly provided by Dr. Andrew Geiser (NCI/NIH,
Bethesda, MD, USA). The chloramphenicol acetyltrans-
ferase (CAT) constructs employed were pA1079, pA835
and pAB406 [21] containing 21079, 2835, or 2406 bp 59
from the A transcription start-site of the murine TGF-b1
gene (the pAB406 also contained the B start site, which lies
290 bp 39 to the A site). The pAoCAT construct, which
contains the CAT gene without regulatory elements, and
the pSV2CAT construct, which contains the CAT gene
linked to the SV40 promoter/enhancer, were used as
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negative and positive controls, respectively. Transient
transfections were performed on cells grown to 60% con-
fluence in DMEM/10% FCS with a glucose concentration
of 180 mg/dl. The growth medium was removed, cells were
washed twice with PBS, and 2 mg of test plasmid and 1 mg
of control b-galactosidase plasmid (PLENX2; kindly pro-
vided by Dr. Pamela Norton) were added to cells with
Superfect reagent (Qiagen, Chatsworth, CA, USA) in a
total volume of 600 ml with DMEM/10% FCS for three
hours. The medium was then removed, cells washed once
with PBS and fresh medium (DMEM/10% FCS) was added
for 16 hours. Cells were then washed twice with PBS and
serum-free DMEM was added containing either 100 mg/dl
or 450 mg/dl glucose for 24 hours. Additionally, in several
experiments TGF-b1 (1 ng/ml) or PMA (100 nM) was
added as positive controls for stimulation of TGF-b1
promoter activity. Cells were harvested with TEN buffer
(40 mM Tris-HCl, pH 7.5, 0.1 mM EDTA, 150 mM NaCl)
and then lysed with three cycles of freeze-thaw, spun down
for 15 minutes and the supernatant assayed for b-galacto-
sidase activity [32]. Based on equivalent amounts of b-ga-
lactosidase activity, the cell lysates were added to initiate
the CAT enzyme assay using 14C-chloramphenicol (Amer-
sham) as previously described [14, 33, 34]. CAT enzyme
activity was expressed as the percent acetylated chloram-
phenicol compared with total chloramphenicol. Maximal
CAT enzymatic activity was taken as that measured with
the pSV2CAT construct, and relative CAT activities of the
TGF-b1 promoter constructs were expressed as % of
pSV2CAT.
Electrophoretic mobility shift assay (EMSA)
Nuclei were derived from rested cells grown in fresh
DMEM/0.5% FCS containing either 100 mg/dl or 450
mg/dl glucose for 24 hours. Nuclear proteins were isolated
as described [35]. The probe used encoded a putative
glucose responsive element (CACGTG) identified at posi-
tion 2641 to 2636 of the murine TGF-b1 gene. The sense
strand was a 20-mer oligonucleotide (59AAGCAG-
GCACGTGGACTCTG39) that was chemically synthesized
(Bioserve Biotech; Laurel, MD, USA) and annealed to its
complementary strand. To prove specificity of nuclear
binding to the CACGTG element, a 20-mer probe was
synthesized (59AAGCAGGCGACGAGACTCTG39) con-
taining a mutated CACGTG site. The probe was end-
labeled with a-32P-ATP (Amersham) using T4 polynucle-
otide kinase (Promega) [36]. Nuclear proteins (10 mg) were
incubated with 105 cpm of probe for 30 minutes at 4°C in
buffer containing 12 mM HEPES, pH 7.4, 4 mM Tris-HCl,
pH 7.5, 60 mM KCl, 5 mM MgCl2; 1 mg of poly dI:C, 5 mg
bovine serum albumin, and 2 ml glycerol. The protein:DNA
complex was resolved on a 6% non-denaturing polyacryl-
amide gel and dried, followed by autoradiography.
Statistics
The data are presented as means (6 SE) with N indicating
the number of different experiments. Statistical analysis
between two groups was performed by a paired or unpaired
t-test, as appropriate. P , 0.05 was considered a significant
difference.
RESULTS
High glucose stimulates TGF-b1 bioactivity and protein
production
Murine mesangial cells (MMCs) cultured in media con-
taining normal (100 mg/dl) or high glucose (450 mg/dl)
exhibited a sustained, time-dependent increase in the ab-
solute amount of total (latent 1 active) TGF-b1 protein
secretion (measured by ELISA and expressed per total cell
protein; Fig. 1A). Supernatants of cells cultured in high
glucose for 24 hours displayed a 32% increase of total
TGF-b1 protein secretion as compared with cells grown in
normal glucose. At 48 hours there was a 48% increase, at 72
hours there was a 45% increase and at 96 hours a 26%
increase. The iso-osmotic addition of mannitol did not
cause a significant change in total TGF-b1 protein secre-
tion (Fig. 1A). The magnitude of increase in high glucose
may have been blunted by the concomitant hypertrophy of
the cells. To correct for the latter effect, we also measured
total TGF-b1 protein secretion per cell number (Fig. 1B).
After 72 hours of culture in high glucose, MMCs displayed
a 90% increase of total TGF-b1 protein secretion per cell
number (2.73 6 0.21 in high glucose vs. 1.44 6 0.11 ng/106
cells in normal glucose; mean 6 SE, N 5 8; P , 0.05).
MMCs cultured in 450 mg/dl glucose also demonstrated an
increase in TGF-b1 bioactivity (measured by the mink-lung
epithelial cell bioassay) compared with cells cultured in 100
mg/dl glucose (Fig. 1B). At 72 hours MMCs cultured in
high glucose demonstrated a 47% increase in TGF-b1
bioactivity compared with normal glucose. Bioactive
TGF-b1 production did not exceed 10% of the amount of
total TGF-b1 protein in these cells.
High glucose increases steady-state TGF-b1 mRNA level
but does not alter TGF-b1 message stability
The increase in the TGF-b1 mRNA steady-state level in
MMC by high glucose concentration was time-dependent.
Cells cultured for 24 hours in 450 mg/dl glucose displayed
a slight increase in the TGF-b1 mRNA level; however,
after 48 hours of culture in high glucose, the mRNA level
increased by almost twofold compared with cells grown in
100 mg/dl glucose (Fig. 2 A, B). The magnitude of this
effect persisted after 72 hours (not shown). The increase in
TGF-b1 mRNA level by high glucose at 48 hours was also
dose-dependent (Fig. 2C), with maximal effect seen at 450
mg/dl glucose, and no further increase at 600 mg/dl.
To examine if high glucose affected transcript stability,
cells that had been grown in either 100 or 450 mg/dl glucose
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for 48 hours were treated with actinomycin D for an
additional period up to 16 hours to inhibit gene transcrip-
tion. Actinomycin treatment resulted in a progressive decay
in message level over time; the rate of decay was of
equivalent magnitude in cells grown in either normal or
high glucose (Fig. 3). After five hours of actinomycin
treatment the TGF-b1 mRNA level was 49% of the level
without actinomycin in cells grown in normal glucose.
Similarly, the TGF-b1 mRNA level was 48% of the level
without actinomycin in cells grown in high glucose (Fig.
3B). At each time point, the ratio of TGF-b1 mRNA
relative to 18S was virtually unchanged when comparing
cells grown in high versus normal glucose. Therefore, the
increase in the steady-state level of TGF-b1 mRNA in-
duced by high ambient glucose in MMCs is not due to
increased mRNA stability.
High glucose stimulates TGF-b1 gene transcription rate
in murine mesangial cells
To confirm that the increase in the steady-state level of
TGF-b1 mRNA by high glucose is due to increased gene
transcription rate, MMCs were grown in 100 or 450 mg/dl
glucose for 24 hours and in vitro gene transcription rate was
measured by the nuclear run-on assay as described in the
Methods section. Figure 4 demonstrates that TGF-b1 gene
transcription rate (when controlled for gene expression of
ribosomal 18S RNA) is stimulated by 73 6 6% (mean 6 SE;
N 5 3; P , 0.05) in cells grown in high versus normal
glucose for 24 hours. As would be expected, the nonspecific
vector DNA did not hybridize with nuclear RNA from
either normal or high glucose (Fig. 4). Note that the
magnitude of stimulation of gene transcription rate by high
glucose after 24 hours shown in Figure 4 is comparable to
the observed increase in steady-state TGF-b1 mRNA level
after 48 hours depicted in Figure 2. These results are
consistent with the conclusion that high glucose stimulates
TGF-b1 mRNA level predominantly by a transcriptional
mechanism.
High glucose stimulates TGF-b1 promoter activity
Murine mesangial cells were transiently transfected with
varying lengths of the murine promoter of TGF-b1 linked
to the CAT reporter gene. The media were then changed to
normal or high glucose concentration. As noted in Figure 5,
there was a consistent and significant stimulation in CAT
reporter activity with the pA835 construct (corrected for
transfection efficiency using b-galactosidase) when cells
were grown for 24 hours in high glucose media. A shorter
construct (pAB406) did not demonstrate stimulation in
high glucose media; this suggests that an element may exist
in the region between 2406 and 2835 of the murine
TGF-b1 gene that could be glucose-responsive. There was
low basal CAT activity and no significant stimulation with a
longer construct (pA1079), possibly because of the pres-
ence of negative regulatory elements that are known to
exist in the upstream promoter region [21]. To evaluate
whether the pA835 construct also confers stimulation by
other known activators of the TGF-b1 promoter, additional
Fig. 1. Effect of glucose concentration on bioactivity and total secretion
of transforming growth factor-b1 (TGF-b1) in murine mesangial cells
(MMCs). (A) Conditioned media from MMCs grown for 24 to 96 hours in
DMEM/0.5% FCS containing either normal (N; 100 mg/dl) or high (H;
450 mg/dl) D-glucose concentration or iso-osmotic D-mannitol (M; 1 350
mg/dl) were assayed by ELISA for total TGF-b1 protein secretion (latent
1 active) per total cell protein content. The conditioned media from cells
grown in high glucose demonstrate a persistent increase in total TGF-b1
secretion compared with cells grown in normal glucose (N 5 6; *P , 0.05
vs. H). Mannitol did not cause a significant change in total TGF- b1
secretion. (B) Conditioned media from MMCs grown in DMEM/0.5%
FCS containing either normal (o) or high (f) glucose concentration were
assayed for either TGF-b1 bioactivity by the mink lung epithelial cell
reporter assay or total TGF-b1 secretion (latent 1 active) by ELISA as
outlined in the Methods section. Data are mean 6 SE. Freshly harvested
conditioned media from MMCs grown in high glucose for 72 hours
demonstrate a 47% increase in TGF-b1 bioactivity (N 5 8; *P , 0.05)
when compared with normal glucose. These conditioned media demon-
strate approximately 90% increase in total TGF-b1 protein secretion
compared with cells grown in normal glucose (N 5 8; *P , 0.05).
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experiments were performed and the data are shown in
Table 1. The addition of exogenous TGF-b1 (1 ng/ml) led
to a similar degree of stimulation of CAT activity in the
presence of normal or high glucose. Short-term treatment
(6 hr) with the phorbol ester PMA also stimulated pA835
activity. The degree of stimulation of pA835 activity by high
glucose alone ranged between 60% (Fig. 5) and nearly
twofold (Table 1), and is commensurate with the degree of
stimulation observed by high glucose in the nuclear run-on
studies shown in Figure 4.
High glucose stimulates nuclear protein binding to a
putative glucose-responsive element
Analysis by EMSA was performed on nuclear proteins
derived from MMCs grown in various glucose concentra-
tions. Nuclear proteins were mixed with a 32P-labeled
Fig. 2. Northern blot analysis of total RNA isolated from murine mes-
angial cells (MMCs). Representative autoradiogram (A) of RNA from
cells grown in high glucose (H; 450 mg/dl) for 48 hours demonstrating
increased level of the 2.5-kb TGF-b1 mRNA (relative to 18S) as compared
with cells grown in normal glucose (N; 100 mg/dl). Values in (B) are
mean 6 SE, N 5 5, showing significant stimulation of TGF-b1 mRNA at
48 hours but not 24 hours in high glucose (f) as compared with normal
glucose (o) (*P , 0.05). (C) Representative autoradiogram of RNA from
cells grown for 48 hours demonstrating a progressive increase in TGF-b1
mRNA (relative to 18S) with increasing glucose concentrations (215, 330,
450 and 600 mg/dl) compared with cells grown in 100 mg/dl. The peak
effect was observed at glucose concentrations of 450 to 600 mg/dl. The
addition of the phorbol ester PMA (100 nM) to media containing 100
mg/dl glucose for the last six hours of culture also caused an increase in
TGF-b1 mRNA.
Fig. 3. TGF-b1 message stability in MMCs. Representative Northern
blot (A) of total RNA isolated from MMCs grown in either normal (N; 100
mg/dl) or high (H; 450 mg/dl) glucose for 48 hours and then treated with
Actinomycin D (5 mg/ml) to inhibit gene transcription for the time points
indicated in hours. The stimulation of TGF-b1 mRNA level by high
glucose persists at all time points following treatment with Actinomycin D.
Data in (B) represent the profile of TGF-b1 mRNA decay (relative to
18S) following treatment with Actinomycin D for cells grown in either
normal (– – –) or high (——) glucose. The estimated half-life of TGF-b1
message is approximately five hours in either media. Data points represent
mean values from three different experiments. Curves represent best-fit
lines.
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synthetic DNA probe encoding 2648 to 2629 bp of the
murine TGF-b1 promoter that contains a putative glucose
responsive element, CACGTG [26]. Figure 6 demonstrates
enhanced binding of the DNA probe with nuclear protein
obtained from cells grown in 450 mg/dl glucose for 24 hours
(lane 5) as compared with 100 mg/dl glucose (lane 3).
There appeared to be four distinct retarded bands that
were all increased in density to various extents by the high
glucose concentration. To demonstrate specificity of bind-
ing, excess unlabeled (‘cold’) probe was added to the
reaction mix and this caused a marked decrease of binding
of protein to the labeled probe (Fig. 6). In addition, a
mutated probe lacking the intact CACGTG site failed to
bind nuclear proteins from either normal or high glucose-
treated MMCs (lanes 8 and 9). Thus, the high glucose
condition stimulates specific binding of nuclear proteins to
DNA fragments containing the CACGTG element in the
murine TGF-b1 promoter.
DISCUSSION
The nature of the factors directly arising as a conse-
quence of hyperglycemia and the steps involved in diabetic
complications are not completely understood. Previous
studies have demonstrated that many of the actions of high
ambient glucose on renal cells resemble those of TGF-b [9,
10]. In fact, the hypertrophic and prosclerotic effects of
high glucose concentration on cultured glomerular mesan-
gial cells [11, 12], glomerular epithelial cells [13], and
proximal tubular epithelial cells [14, 15] are mediated by
autocrine production and activation of TGF-b. The present
study demonstrates that high glucose concentration stimu-
lates the transcriptional activation of the TGF-b1 gene in
Fig. 4. High glucose stimulates TGF-b1 gene transcription rate in
MMCs. In vitro gene transcription rates were measured in nuclei isolated
from MMCs grown for 24 hours in media containing either normal (100
mg/dl) or high (450 mg/dl) glucose as outlined in the Methods section.
MMCs grown in high glucose demonstrate a 73 6 6% increase (mean 6
SE; N 5 3, P , 0.05) in TGF-b1 gene transcription rate (relative to 18S)
compared with cells grown in normal glucose. Densitometric measure-
ments of TGF-b1 transcription rate were calculated relative to 18S. Note
that nuclear RNA did not hybridize with the nonspecific vector pBsks.
Fig. 5. High glucose increases CAT activity of pA835 construct contain-
ing a putative glucose responsive element in the TGF-b1 promoter.
Representative thin layer chromatography plate (A) after separation of
acetylated 14C-chloramphenicol (CAT activity) from unacetylated fraction
of extracts of MMCs transiently transfected with the pA835 construct.
Lanes 1 and 2 are from MMCs grown in normal glucose (N; 100 mg/dl)
and lanes 3 and 4 are from MMCs grown for 24 hours in high glucose (H;
450 mg/dl). A beta-galactosidase-containing plasmid was cotransfected to
normalize for differences in transfection efficiency. Data in (B) are
mean 6 SE for relative CAT activities of the pAB406, pA835, and pA1079
constructs transiently transfected into MMCs and grown in normal (o) or
high glucose (f) for 24 hours. High glucose induces a 60% increase in
relative CAT activity only in those cells transfected with the pA835
construct. Data represent five different transfection experiments, and
CAT activity of each construct is expressed relative to maximal activity
seen with the positive control pSV2CAT construct (*P , 0.05).
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murine mesangial cells. The degree of transcriptional acti-
vation at 24 hours correlates well with the magnitude of
mRNA stimulation at 48 hours and of the protein level at
72 hours. In addition, high glucose did not significantly
affect mRNA stability, consistent with the view that the
mechanism underlying the stimulation of TGF-b1 by high
glucose is primarily due to transcriptional activation. It is
conceivable that enhanced TGF-b bioactivity by high glu-
cose is also regulated by the conversion of latent to active
TGF-b. Studies in other cell types have demonstrated that
the latent moiety may be affected by various conditions
[37]. We found a 47% increase in active TGF-b whereas
total TGF-b1 protein (per cell number) was increased by
almost 90% after 72 hours in culture in 450 mg/dl glucose.
Therefore, enhanced conversion of latent TGF-b1 to active
TGF-b1 alone does not account for the entire high glucose
effect.
Increased mRNA expression in high glucose media is
most likely due to enhanced synthesis of TGF-b1 mRNA.
This supposition was confirmed by the nuclear run-on
studies wherein we found a 73% stimulation of TGF-b1
gene transcription rate. Promoter activity studies also dem-
onstrated a similar degree of stimulation with one of the
promoter-reporter constructs (pA835). A shorter construct
(pAB406) did not exhibit significant stimulation by high
glucose, suggesting that a glucose-responsive element re-
sides in the region between 2406 and 2835 located 59 to
the A start site. Inspection of this region identified a
sequence between 2641 and 2636 that is similar to a
glucose-responsive sequence previously described in the
S14 and pyruvate kinase genes [25, 26]. This region con-
tains the CACGTG sequence which is a consensus site for
the c-myc family of transcription factors. EMSA studies
employing the native sequence (2648 to 2629) in the
murine TGF-b1 promoter as a probe demonstrated en-
hanced binding of nuclear proteins derived from cells
grown in high glucose. A recent report by Shih, Liu and
Towle demonstrated that the presence of two CACGTG
elements separated by a 5 bp sequence conferred greater
degree of glucose-responsiveness than a single CACGTG
site [38]. As the native TGF-b1 promoter in the mouse
Fig. 6. High glucose stimulates nuclear protein binding to a putative
glucose-response element. A 20-bp oligonucleotide probe encoding the
sequence between 2648 and 2629 of the murine TGF-b1 promoter was
end-labeled and used in the EMSA as described in the Methods. Lane 1
represents probe alone. Probe was incubated with nuclear proteins from
MMCs grown in low glucose (50 mg/dl: lane 2), normal glucose (NG; 100
mg/dl; lane 3), intermediate high glucose (300 mg/dl: lane 4) or high
glucose (HG; 450 mg/dl; lane 5). Four discrete bands were gel-shifted
(arrows) by nuclear proteins and increased in density in 450 mg/dl glucose
(lane 5). For specificity control, nuclear proteins from MMCs cultured in
450 mg/dl glucose were incubated in the presence of 100-fold excess ‘cold’
probe along with labeled probe (lane 6) prior to analysis by EMSA. To
further prove specificity of nuclear binding to the CACGTG element, a
mutated 20-mer probe was synthesized containing a scrambled CACGTG
site, and was added to nuclear proteins from MMCs cultured in 100 or 450
mg/dl glucose (lanes 8 and 9, respectively). Lane 7 represents mutated
probe alone, without nuclear proteins.
Table 1. Effects of glucose, TGF-b1, and phorbol ester on CAT





100 — 15.8 6 1.2
450 — 29.6 6 4.6a
100 TGF-b1 39.6 6 4.3a
450 TGF-b1 42.2 6 1.3a
100 PMA 41.1
MMCs were transiently transfected with the pA835 construct. A
beta-galactosidase-containing plasmid was cotransfected to normalize for
differences in transfection efficiency. Cells were cultured in either normal
(100 mg/dl) or high (450 mg/dl) glucose for 24 hours. Cells were also
treated with either TGF-b1 (1 ng/ml) or the active phorbol ester PMA
(100 nM, 6 hours), known activators of TGF-b1 promoter activity. CAT
activity is expressed relative to maximal activity seen with the pSV2CAT
construct. Data are mean 6 SE of three different transfection experiments
(except for two experiments using PMA). Abbreviations are in the
Appendix.
a P , 0.05 vs. 100 mg/dl glucose
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contains only one CACGTG site, this may explain the
relatively modest degree of stimulation of the TGF-b1
promoter by high glucose. However, it should be noted that
the degree of stimulation of TGF-b1 by high glucose media
was generally of equivalent magnitude at the protein,
mRNA, and transcriptional levels. Additionally, our previ-
ous studies in diabetic mice and rats have demonstrated
that kidney TGF-b1 mRNA level is increased by two- to
threefold within the first week of development of diabetes
mellitus [9, 30].
Our results demonstrate that high glucose alone is a
sufficient stimulus for the enhanced synthesis and secretion
of TGF-b1 into the conditioned medium of murine mes-
angial cells. This stimulation likely accounts for the high
glucose-mediated stimulation of collagen biosynthesis by
mesangial cells without the need for exogenous addition of
other growth factors [12]. We cannot, however, exclude a
contribution in vivo from autocrine production of other
growth factors such as platelet-derived growth factor [17,
39].
High glucose has been demonstrated to affect the for-
mation in mesangial cells of the transcription factors c-jun
and c-fos [23], components of the AP-1 heterodimeric
complex. This complex binds with high affinity to TPA
(phorbol ester)-responsive elements (TRE). A recent re-
port by Wilmer and Cosio indicates that high glucose
increases DNA binding of AP-1 in human mesangial cells,
through an effect involving protein kinase C (PKC)
activation and post-translational modifications of the tran-
scription factor complex [40]. Previous reports have
demonstrated that PKC inhibitors attenuate the high glu-
cose-induced TGF-b1 mRNA stimulation in mesangial
cells in culture [41]. In addition, selective inhibition of the
PKC-b isoform in diabetic rats attenuates diabetes-induced
stimulation of TGF-b1 mRNA in glomeruli [42]. Treat-
ment with phorbol esters, which are known to stimulate the
classic PKC isoforms, can stimulate TGF-b1 gene tran-
scription via TRE sites [43]. However, our studies suggest
that there are other regions in the murine TGF-b1 pro-
moter (for example, between 2406 and 2835, which do not
contain consensus AP-1 binding sites) that exhibit glucose-
responsiveness, and likely are regulated via non-AP1 tran-
scription factors. It has been demonstrated that the com-
bined treatment with high glucose plus TGF-b1 causes
phosphorylation of a cAMP responsive element binding
(CREB) protein in rat mesangial cells [44], and we have
recently demonstrated that TGF-b1-induced CREB phos-
phorylation can be blocked by inhibition of protein kinase
A in murine mesangial cells [45]. Thus, additional studies
are required to identify other signaling pathways and
transcription factors that may be involved in the transcrip-
tional activation of TGF-b1 by high glucose. It is quite
possible that a combination of signaling pathways and
transcription factors with cross-talk between them is nec-
essary to generate an optimal stimulation of the TGF-b
system by high ambient glucose in specific cell types that
are relevant to diabetic renal disease [46].
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APPENDIX
Abbreviations used in this article are: ATP, adenosine 59-triphosphate;
CAT, chloramphenicol acetyltransferase; CREB, cAMP responsive ele-
ment binding; CTP, cytidine 59-triphosphate; DMEM, Dulbecco’s modi-
fied essential medium; DTT, dithiothreitol; EMSA, electrophoretic mo-
bility shift assay; FCS, fetal calf serum; GTP, guanosine 59-triphosphate;
MMC, murine mesangial cells; PAI-1, plasminogen activator inhibitor-1;
PKC, protein kinase C; PMA, phorbol 12-myristate 13-acetate; TGF-b,
transforming growth factor-beta; UTP, uridine triphosphate.
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